Page last updated: 2024-11-01

omeprazole and Parotid Neoplasms

omeprazole has been researched along with Parotid Neoplasms in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Parotid Neoplasms: Tumors or cancer of the PAROTID GLAND.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwai, H1
Nakamichi, N1
Nakae, K1
Konishi, M1
Inaba, M1
Hoshino, S1
Baba, S1
Amakawa, R1

Other Studies

1 other study available for omeprazole and Parotid Neoplasms

ArticleYear
Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
    The Laryngoscope, 2009, Volume: 119, Issue:8

    Topics: Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; G

2009